• Contact Us
  • Sign Up
  • TWITTER
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Animal Health
  • Phytobiome
  • Finance
    • Finance Articles
    • Microbiome Stocks
  • Drug Database
    • About
    • Login/ Register
  • Issue Archive
  • Advertise

Month: July 2019

Pharma & Human Health

Synlogic Reports Positive Top-line Data from Phase 1/2a Study of SYNB1618 in Patients with PKU

July 16, 2019 Staff Editor

Synlogic, Inc., (Nasdaq: SYBX), a clinical stage company developing a novel class of Synthetic BioticTM therapeutics, announced positive top-line clinical data from patient cohorts of a randomized, double-blind, placebo-controlled Phase 1/2a study of SYNB1618, which […]

Pharma & Human Health

Researchers Urge Changes in the Language of the Microbiome

July 12, 2019 Jim Barlow

Philosopher Nicolae Morar was perplexed by various metaphors tossed about by scientists studying the human microbiome. Microbiologist Brendan Bohannan was sure that thinking of the human body as an ecosystem correctly framed the research being […]

Pharma & Human Health

4D pharma plc Commences Phase I/II Asthma Trial

July 8, 2019 Staff Editor

A multicentre Phase I/II double-blind, placebo-controlled study of MRx-4DP0004 in patients with poorly controlled asthma has now commenced. The study will enrol 90 asthma patients not adequately controlled on their current inhaler maintenance therapy. Patients […]

Pharma & Human Health

Ritter Pharmaceuticals Announces Last Patient Last Visit in its Phase 3 “Liberatus” Clinical Trial of RP-G28 for Lactose Intolerance

July 6, 2019 Staff Editor

Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, today announced that the last patient has completed their final […]

Editor's Choice

Why Flow Cytometry Could be the Probiotics Enumeration Method of Tomorrow

July 5, 2019 Nina Vinot and Marco Pane

Probiotics and Analytical Implications Probiotic products are booming all over the World, in a diversity of foods from yogurt to kefir, kimchi, kombucha, sauerkraut and enriched products as well as dietary supplements, with a global market […]

Editor's Choice

Engineering Phage Particles: An Interview with Xavier Duportet, CEO & Co-founder, Eligo Bioscience

July 4, 2019 Staff Editor
Editor's Choice

5-minute Microbiome Science Roundup: June 2019

July 4, 2019 Kristina Campbell

Some especially good work was published in the microbiome scientific literature this past month. Several of the papers below constitute important investigations that are likely to shape new areas of study or spur new medical […]

Editor's Choice

Synthetic Bacterial Memory Circuits Enable Microbial Diagnostics for Sensing Biomolecules in the Gut

July 4, 2019 Lindsay Brownell

Millions of people take capsules of probiotics with the goal of improving their digestion, but what if those bacteria were also able to detect diseases in the gut and indicate when something is awry? New […]

Pharma & Human Health

New Study Finds Key Factors That Shape the Skin Microbiome, Including Age and Lifestyle Choices

July 3, 2019 Staff Editor

Scientists are advancing our understanding of how the skin microbiome—the diverse community of bacteria, fungi, and other microbes living on the skin’s surface—is important for skin health. Knowing what shapes the skin microbiome may provide […]

Pharma & Human Health

Ken Blount, CSO of Rebiotix Appointed Chairman of MTIG

July 3, 2019 Staff Editor

The Microbiome Therapeutics Innovation Group (MTIG) announced today the appointment of a new chairman, Ken Blount, Ph.D., Chief Scientific Officer of Rebiotix, Inc. Dr. Blount replaces Tom DesRosier, Esq., Chief Legal Officer of Seres Therapeutics, […]

Pharma & Human Health

New Research shows link between Parkinson’s disease and the microbiome

July 2, 2019 Staff Editor

A simple saliva swab may provide an accurate way of detecting Parkinson’s disease in its earliest stages, according to a study just published in the journal Plos One. In a paper titled “The oral microbiome […]

Posts navigation

« 1 2

Sign Up to Free Newsletter

The Microbiome Drug Database

Advertisments

The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry

Market Reports
October 26, 2020
Abstract Year 2020 has been a pivotal year for microbiome-focused drug companies. This year the industry saw the release of two much-anticipated Phase 3 studies, which showed positive results and set the stage for new [...]

Editor’s Choice

  • Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19
    January 20, 2021
  • Poor gut health connected to severe COVID-19, new review shows
    January 18, 2021
Categories
  • Animal Health
  • Editor's Choice
  • Finance
  • Market Reports
  • Pharma & Human Health
  • Phytobiome & Environment
  • Premium Content
  • Reports
  • Sponsored Content
  • Uncategorized
  • Video
  • Webinar
sign up

Sign up to the Microbiome Times newsletter